Category Archives: Market-Health Care

Memory Loss Side Effects with Prescription Drugs

A number of prescription drugs, especially in combination with each other, can cause unintended memory loss symptoms. Some of the more common prescription medications known to cause memory problems are Benzodiazepines (anti-anxiety meds) such as lprazolam (Xanax), chlordiazepoxide (Librium), clonazepam (Klonopin), diazepam (Valium), flurazepam (Dalmane), lorazepam (Ativan), midazolam (Versed), quazepam (Doral), temazepam (Restoril) and triazolam […]

Merck Advances BACE Inhibitor Trial for Alzheimer’s Disease

Merck announced last month that it is moving ahead with MK-8931, an experimental BACE inhibitor drug designed to slow the production of amyloid beta protein in the brain, one of the hallmarks of Alzheimer’s disease. Beta secretase (BACE) inhibitors work by interfering with the process that creates amyloid beta protein in the first place, in […]

High Blood Pressure and Cognitive Decline

More confirmation that high blood pressure (hypertension) directly impacts brain health from this study in the British Medical Journal. The BMJ study followed over 5,000 older adults (average age of 75) for three years, measuring both blood pressure and cognitive health during medical visits performed four times a year. The researchers found a consistent pattern […]

Brain Health and Wellness Apps

The Health 2.0 Conference in Silicon Valley this week provided a forward-looking view on what health care could look like in the next several years. Many of the themes revolved around real time (and personalized) health monitoring, and the growing ability for people to take control of their own health care choices. There are a […]

Using Blood Protein Markers for Brain Health Screening

Can a simple blood test be possible to screen for Alzheimer’s disease and other brain conditions? New research discussed at the Alzheimer’s Association International Conference (AAIC) last month suggests that reliable, low cost blood serum analysis for brain biomarkers is a possibility within the next decade or so. Blood tests are an attractive screening option […]

Should Medicare Cover the Cost of Brain Imaging Tests for Alzheimer’s Diagnosis?

I’m at the Alzheimer’s Association International Conference (AAIC) in Boston this week, and one of the most discussed topics is the power of brain imaging tests to detect amyloid beta protein in the brain, one of the main hallmarks of Alzheimer’s disease pathology. Positron Emission Tomography (PET) imaging tests can identify amyloid beta deposits in […]

Drug Combo Might Repair Alzheimer’s Damage

This interesting study on combining two well known medications to treat neural synaptic damage prevalent in Alzheimer’s disease shows some promise. Researchers at the Sanford-Burnham Institute in San Diego looked at the possibility of reversing damage caused by the release of excessive amounts of the neurotransmitter glutamate from astrocytes that are located adjacent to neurons. […]

Cognitive Screening & Testing Report Released

Computerized Cognitive Assessment Products – Neurocognitive Screening for ADHD, Memory Loss, Alzheimer’s, Dementia, Traumatic Brain Injury Since our last report in 2011, the market for computerized cognitive assessment, screening and testing has continued to expand. Key drivers for this market and growing technology product base include: An Aging Global Population: 500 million people in the […]